- Home
- DECK vs DXCM Comparison
DECK vs DXCM Comparison
Compare DECK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DECK | DXCM |
|---|---|---|
| Founded | 1973 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 33.9B |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DECK | DXCM |
|---|---|---|
| Price | $90.14 | $88.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 21 |
| Target Price | ★ $122.45 | $85.33 |
| AVG Volume (30 Days) | 2.3M | ★ 5.2M |
| Earning Date | 05-21-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.90 | ★ 47.18 |
| EPS | 0.94 | ★ 1.15 |
| Revenue | ★ $5,472,296,000.00 | N/A |
| Revenue This Year | $11.16 | $14.46 |
| Revenue Next Year | $6.96 | $12.31 |
| P/E Ratio | $99.03 | ★ $78.04 |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $78.91 | $54.11 |
| 52 Week High | $125.45 | $91.99 |
Technical Indicators
Market Signals| Indicator | DECK | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 34.14 | 64.15 |
| Support Level | $78.91 | $62.02 |
| Resistance Level | $105.61 | N/A |
| Average True Range (ATR) | 2.70 | 2.72 |
| MACD | -0.65 | 0.64 |
| Stochastic Oscillator | 6.91 | 81.39 |
Price Performance
Historical ComparisonAbout DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.